Atopic Dermatitis (AD) Case Study

Click here for a PDF version of this case study

AD case study

Innovation in dermatology research icon


Innovaderm successfully managed this AD study
and this resulted in:

Enrollment completed 2 months earlier than planned;
Innovaderm CRU recruited 33% of patients


Study Characteristics

    • Study Phase: Ib
  • Patient Population: 36 subjects with moderate to severe AD
  • IP Route of Administration: Systemic - Oral
  • Site distribution: 10 sites in 2 countries (USA and Canada)
  • Study Design: Randomized, sequential, placebo-controlled, double-blind | Multiple ascending dose (MAD): 3 sequential cohorts
  • Study procedures: 4.5 mm punch skin biopsies, photographs, biomarker analysis, skin microbiome, pharmacokinetics, tape stripping and efficacy-safety assessments



Study Challenges

    • Recruitment during summer months; Seasonality impacts on AD flares
    • Short treatment duration; 4-week treatment period
    • Data and Safety Monitoring Board (DSMB) after each cohort; Challenging to manage without affecting recruitment



Key Success Factors & Strategies

Phone interview icon Recruitment completed in 6 months vs planned 8 months

Site engagement Outstanding contribution by Innovaderm's Clinical Research Unit



Recruitment Curve


Enrollment target reached 2 months ahead of schedule




    Contact us

    Get notified to have the latest trends and be at the forefront of dermatology clinical research and innovation.

    Subscribe to our newsletter

    Innovaderm Research Wave